First Wave BioPharma, Inc.
11:45 AM - 12:00 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 104A
First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
Ticker:
FWBI
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Florida
Company HQ Country:
United States
Year Founded:
2014
Main Therapeutic Focus:
Gastrointestinal
Lead Product in Development:
Adrulipase
Development Phase of Primary Product:
Phase II
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
